Rybelsus is an oral GLP-1 receptor agonist used once daily to improve blood sugar control in adults with type 2 diabetes. It contains semaglutide and works by increasing insulin release when needed, reducing glucagon production, and slowing digestion to help regulate blood glucose levels. Available in 3 mg, 7 mg, and 14 mg tablets, it is taken on an empty stomach with water and used alongside diet and exercise under medical supervision.